Entries of Wessels, Lodewyk F.A. on the publication server
 | Up a level |
Jump to: 2023
Number of items: 2.
2023
Gil-Jimenez, Alberto, van Dorp, Jeroen 
, Contreras-Sanz, Alberto, van der Vos, Kristan, Vis, Daniel J., Braaf, Linde, Broeks, Annegien, Kerkhoven, Ron, van Kessel, Kim E.M., Ribal, María José, Alcaraz, Antonio, Wessels, Lodewyk F.A., Seiler, Roland, Wright, Jonathan L., Mengual, Lourdes, Boormans, Joost, van Rhijn, Bas W.G., Black, Peter C. and van der Heijden, Michiel S.
(2023)
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer.
European Urology 83 (4), pp. 313-317.
Fulltext not available.
, Contreras-Sanz, Alberto, van der Vos, Kristan, Vis, Daniel J., Braaf, Linde, Broeks, Annegien, Kerkhoven, Ron, van Kessel, Kim E.M., Ribal, María José, Alcaraz, Antonio, Wessels, Lodewyk F.A., Seiler, Roland, Wright, Jonathan L., Mengual, Lourdes, Boormans, Joost, van Rhijn, Bas W.G., Black, Peter C. and van der Heijden, Michiel S.
(2023)
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer.
European Urology 83 (4), pp. 313-317.
Fulltext not available.
Gil-Jimenez, Alberto, van Dorp, Jeroen, Contreras-Sanz, Alberto, van der Vos, Kristan, Vis, Daniel J., Braaf, Linde, Broeks, Annegien, Kerkhoven, Ron, van Kessel, Kim E.M., Ribal, María José, Alcaraz, Antonio, Wessels, Lodewyk F.A., Seiler, Roland, Wright, Jonathan L., Mengual, Lourdes, Boormans, Joost, van Rhijn, Bas W.G., Black, Peter C. and van der Heijden, Michiel S.
(2023)
Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83:313–17].
European Urology 83 (6), e165.
Fulltext not available.